1.9596
Finanzdaten der Vor Biopharma Inc-Aktie (VOR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
|
723.90%
274.28
|
33.29 | 31.31 | 28.51 | 29.04 |
Operating Income/Loss |
723.90%
-274.28
|
-33.29 | -31.31 | -28.51 | -29.04 |
Nonoperating Income/Loss |
161.51K%
-1,299.38
|
0.805 | 0.599 | 0.954 | 1.196 |
Income/Loss From Continuing Operations Before Tax |
4,744%
-1,573.67
|
-32.49 | -30.71 | -27.56 | -27.84 |
Income/Loss From Continuing Operations After Tax |
4,744%
-1,573.67
|
-32.49 | -30.71 | -27.56 | -27.84 |
|
4,744%
-1,573.67
|
-32.49 | -30.71 | -27.56 | -27.84 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
0.36%
125.27
|
124.82 | 0.4396 | 68.47 | 68.30 |
Diluted Average Shares |
0.36%
125.27
|
124.82 | 0.4396 | 68.47 | 68.30 |
Basic Earnings Per Share |
4,731%
-12.56
|
-0.26 | -0.44 | -0.40 | -0.41 |
Diluted Earnings Per Share |
4,731%
-12.56
|
-0.26 | -0.44 | -0.40 | -0.41 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):